Garvan researcher appointed to senior role at new research centre in China

Garvan congratulates Dr Shu Lin, who has been appointed as a Distinguished Professor and Executive Director at the newly established South-West Metabolism and Cardiovascular Research Centre (SMCVRC) in Chongqing, China.
Garvan researcher appointed to senior role at new research centre in China
26 October 2015

The Garvan Institute of Medical Research congratulates Dr Shu Lin, who has been appointed as a Distinguished Professor and Executive Director at the newly established South-West Metabolism and Cardiovascular Research Centre (SMCVRC) in Chongqing, China. Dr Lin will take up his position in late October.

At SMCVRC, Dr Lin will join a small team of outstanding researchers recruited from the United Kingdom, USA and Australia. Together, the leadership team will manage the development of SMCVRC, establishing it as a world-class biomedical research centre.

Dr Lin has had a long and successful association with Garvan. A paediatrician in his home country of China, he obtained his PhD from the University of Wollongong then joined Professor Herbert Herzog’s lab in Garvan’s Neuroscience Division in 2003 as a research officer. He became group leader of the Hypothalamic Function group in 2013, the same year that he became qualified as a medical practitioner in Australia.

Dr Lin’s research at Garvan has focused on how the brain regulates food intake and energy expenditure. In the course of his 12 years here, he has discovered several new hormone signalling pathways and developed a number of cutting-edge technologies for brain imaging. He has published over 50 peer-reviewed research papers, including one in Nature Medicine [1] and two in Cell Metabolism [2,3].

Dr Lin says, “I am delighted to be taking this new direction and to be returning to my native China – and I’d like to take this opportunity to thank the many colleagues who have provided me with training and support during my 12 years at this fantastic institute.”

Executive Director of Garvan, Professor John Mattick AO, says, “We are thrilled that Shu Lin has been recognized and rewarded with this outstanding opportunity to build metabolic and cardiovascular research in one of China’s major cities. He has been an outstanding contributor to Garvan’s science, and his appointment to SMCVRC will strengthen the partnership between Garvan and China in advancing the health of our countries.”

 

 

[1] Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, Corey E, Apple FS, Murakami MM, Lin EJ, Wang C, During MJ, Sainsbury A, Herzog H, Breit SN. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med2007;13:1333-40

[2] Shi YC, Lau J, Lin Z, Zhang H, Zhai L, Sperk G, Heilbronn R, Mietzsch M, Weger S, Huang XF, Enriquez RF, Baldock PA, Zhang L, Sainsbury A, Herzog H, Lin S. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab2013;17:236-48

[3] Yulyaningsih E, Loh K, Lin S, Lau J, Zhang L, Shi Y, Berning BA, Enriquez R, Driessler F, Macia L, Khor EC, Qi Y, Baldock P, Sainsbury A, Herzog H. Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice. Cell Metab. 2014;19:58-72

Related Labs/Groups

Related People